Literature DB >> 11081676

Apoptosis in human cumulus cells in relation to maturation stage and cleavage of the corresponding oocyte.

E Høst1, A L Mikkelsen, S Lindenberg, S Smidt-Jensen.   

Abstract

BACKGROUND: The purpose of this study was to determine the incidence of apoptosis in cumulus cells, and correlate these findings with the maturation stage, fertilization rate and embryo score of the corresponding oocyte, in couples undergoing ICSI due to a male factor.
METHODS: The study group consisted of 21 couples where ICSI was performed. The total number of oocyte-cumulus complexes retrieved was 164. Sperm samples were assessed according to the WHO manual, morphology according to the strict criteria and for the presence of apoptosis. The degree of apoptotic DNA fragmentation was determined using the free 3'OH DNA termini in situ with chemically labeled and unlabeled nucleotides. The study was blinded for the technician involved in the assessments of apoptosis in the cumulus cells, apoptosis and morphology in spermatozoa. Ovarian hyperstimulation was carried out according to a long down regulation protocol using GnRH, recFSH and hCG. A maximum of 3 embryos were transferred on day 2 after ICSI.
RESULTS: This study demonstrated that the incidence of apoptosis was significantly higher in cumulus cells from germinal vesicle and metaphase I oocytes compared to cumulus cells from metaphase II oocytes (p<0.0001). Non-fertilized metaphase II oocytes showed significantly higher incidence of apoptosis in cumulus cells compared to fertilized metaphase II oocytes (p=0.0082). Furthermore, apoptosis in spermatozoa had an impact on the embryo score (p=0.0087).
CONCLUSION: Comparing apoptosis in cumulus cells with maturity of the corresponding oocytes, a significantly higher degree was found related to immature oocytes. Apoptosis in cumulus cells from human metaphase II oocytes impaired the fertilization rate. The degree of fragmentation in the embryo might be correlated to apoptosis in the spermatozoa.

Entities:  

Mesh:

Year:  2000        PMID: 11081676

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

Review 1.  New molecular markers for the evaluation of gamete quality.

Authors:  G Ruvolo; R R Fattouh; L Bosco; A M Brucculeri; E Cittadini
Journal:  J Assist Reprod Genet       Date:  2013-02       Impact factor: 3.412

2.  Hypo-glycosylated hFSH drives ovarian follicular development more efficiently than fully-glycosylated hFSH: enhanced transcription and PI3K and MAPK signaling.

Authors:  Guohua Hua; Jitu W George; Kendra L Clark; Kim C Jonas; Gillian P Johnson; Siddesh Southekal; Chittibabu Guda; Xiaoying Hou; Haley R Blum; James Eudy; Viktor Y Butnev; Alan R Brown; Sahithi Katta; Jeffrey V May; George R Bousfield; John S Davis
Journal:  Hum Reprod       Date:  2021-06-18       Impact factor: 6.353

3.  Effect of GOLPH3 on cumulus granulosa cell apoptosis and ICSI pregnancy outcomes.

Authors:  Dianliang Lin; Jing Ran; Suqin Zhu; Song Quan; Baofeng Ye; Aili Yu; Yuefan Kang; Yuan Lin
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

4.  The use of pituitary adenylate cyclase-activating polypeptide in the pre-maturation system improves in vitro developmental competence from small follicles of porcine oocytes.

Authors:  Kyu-Mi Park; Kyu-Jun Kim; Minghui Jin; Yongquan Han; Kyoung-Ha So; Sang-Hwan Hyun
Journal:  Asian-Australas J Anim Sci       Date:  2019-08-03       Impact factor: 2.509

5.  Discovery of single nucleotide polymorphisms in candidate genes associated with fertility and production traits in Holstein cattle.

Authors:  Sarah D Cochran; John B Cole; Daniel J Null; Peter J Hansen
Journal:  BMC Genet       Date:  2013-06-07       Impact factor: 2.797

Review 6.  Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics.

Authors:  Alberto Revelli; Luisa Delle Piane; Simona Casano; Emanuela Molinari; Marco Massobrio; Paolo Rinaudo
Journal:  Reprod Biol Endocrinol       Date:  2009-05-04       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.